The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis

INTRODUCTION: Treatment-related quality of life (QOL) is an important aspect of diabetes management. Here, we investigated the influence of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on treatment-related QOL in patients with type 2 diabetes mellitus treated with insulin. METHODS: This was a pr...

詳細記述

保存先:
書誌詳細
出版年:Diabetes Ther
主要な著者: Mita, Tomoya, Katakami, Naoto, Shiraiwa, Toshihiko, Yoshii, Hidenori, Gosho, Masahiko, Ishii, Hitoshi, Shimomura, Iichiro, Watada, Hirotaka
フォーマット: Artigo
言語:Inglês
出版事項: Springer Healthcare 2017
主題:
Brief Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5446390/
https://ncbi.nlm.nih.gov/pubmed/28516377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-017-0267-2
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料